it all about the scaffold !!, page-8

  1. 5,318 Posts.
    lightbulb Created with Sketch. 253
    "From the wound dressing trial there doesn`t seem to be any foam offering by KCI that can`t be replaced by Polynovo..." But it looks like KCI are now looking in an entirely different direction.

    KCI throwing $485 million at Systagenix doesn't bode well for a deal with Polynovo. It looks like KCI have hitched their wagon to another horse. I think KCI would rather take over than license.

    What I fail to understand it the infatuation with collagen scaffolds.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.